ARTICLE | Clinical News
Meridia sibutramine regulatory update
October 11, 2010 7:00 AM UTC
FDA ordered Abbott to withdraw obesity drug Meridia sibutramine in the U.S. The agency said Meridia's availability is not justified when comparing the "very modest weight loss" that people achieve on ...